ALTSuLIN

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameALTSuLIN
Drug Alias Nameporcine-derived sertoli cell therapy (ALTuCELL)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionInsulin-like growth factor I receptor agonists
TargetsInsulin-like growth factor I receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 1Laron Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEcuador
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesALTuCELL Inc
China Registration ClassN/A

Develop Information

Active CompaniesALTuCELL Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1Laron Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A